Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Cryoinsufflation in Hidradenitis Suppurativa
Description
The presentation discusses cryo insufflation as a treatment technique for Hidradenitis Suppurativa (HS), aimed at both clinicians and patients. The speaker explains the technique's purpose, particularly for patients with recurrent abscesses or persistent tunnels, emphasizing its off-label nature. Cryo insufflation involves using liquid nitrogen to destroy the lining of sinus tracts or tunnels, with procedural adaptations to minimize patient discomfort and improve effectiveness. The approach is available both through natural openings and via modified techniques like punch cryo insufflation for lesions without openings. Practical guidance includes equipment required, safety protocols, and billing strategies for insurance. The presenter encourages utilization of this method as a less invasive option, highlighting real-time experiences and outcomes from recent cases, and promotes the importance of documenting and billing for these procedures to support a reevaluation of coding associated with HS treatments. Overall, the goal is to equip healthcare professionals with knowledge about cryo insufflation, its application in managing HS, and to foster improved patient care.
View moreConclusions
- Cryo insufflation is a promising technique for treating hidradenitis suppurativa (HS), particularly for persistent lesions.
- This method allows for the destruction of the lining of sinus tracts without the need for anesthesia.
- Patients often experience minimal pain and no adverse events during cryo insufflation procedures.
- Optimal patient selection for cryo insufflation includes those with recurrent or persistent lesions, especially when medical therapies have failed.
- The technique shows potential as an alternative to more invasive surgical options in managing HS.
- Sequential treatments may be required to achieve the desired results, as indicated in preliminary studies.
- Pagliarello C. JAMA Dermatol. 2014;150:765-766.
- Pagliarello C. Dermatol Surg. 2016;42:130-132.
- J Eur Acad Dermatol Venereol. 2019 May;33(5):e221-e223.